AI assistant
Intrasense — Capital/Financing Update 2019
Jan 28, 2019
1447_iss_2019-01-28_4c72cb3b-6bdf-42b2-b3e9-ad4802200ef8.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
Press release Montpellier (France), January 28, 2019 - 5:45 pm CET
In view of its perspectives and cash flow visibility, Intrasense (FR0011179886 - ALINS), specialist in medical imaging software solutions and Myrian®' s creator, announces the suspension of the automatic drawdowns of bounds convertible into shares (« OCA »), initially planned in the contract signed on August 27, 2018 with the Luxembourg fund European High Growth Opportunities Securitization Fund.
The automatic drawdowns of bonds with a nominal value of 125.000 euros every twenty-five trading day, will be suspended as from January 28, 2019 until further notice. Intrasense thanks European High Growth Opportunities Securitization Fund for its flexibility proven on this long-term partnership.
Therefore, the timing of the following drawdown presented in the press release on August 28, 2018 is no longer applicable. Intrasense will disseminate a new press release before drawdown start again.
It is recalled that the OCA follow-up table is available on Intrasense's website, in the « Investors » section, in the « Financial documentation » folder.
Next press release:
Annual results 2018: February 5, 2019 (after trading)
About Intrasense
Founded in 2004, Intrasense develops and markets a unique medical device called Myrian®, a software platform that facilitates diagnosis, decision-making and therapeutic follow-up and makes them more secure. Thanks to Myrian®, more than 800 health institutions spread over 40 countries use a unique and integrated platform supporting all types of imaging modalities (MRI, scanner…). Enriched with expert clinical modules dedicated to specific pathologies, Myrian® also provides a universal image treatment solution that can be fully integrated in any health information system. Intrasense includes 40 employees among which 20 are dedicated to Research & Development. Intrasense has been labelled 'innovative company' by the BPI and invested more than 10 million euros in Research & Development since its creation.
More information on www.intrasense.fr.
Contacts
Intrasense Nicolas Reymond Chief Executive Officer Montpellier - FRANCE Tel: +334 67 130 130 [email protected]
NewCap Investor Relations and Financial Communication Valentine Brouchot - Pierre Laurent Tel: +331 44 71 94 96 [email protected]